About this trial

The goal of this study is to develop a large longitudinal cohort of individuals diagnosed with or at high risk for brain diseases (both neurological and psychiatric in nature), in order to identify risk factors that contribute to neurological and psychiatric diseases over time. The investigators seek to capture relevant information from medical records, electronically administered questionnaires and follow up phone-based interviews. The investigators expect to eventually have sufficient power from our dataset to examine risk factors for a variety of brain disorders, both individually and in aggregate. Our ultimate goal is to offer scientifically validated ways to preserve and promote brain health by working with our patients' needs and tracking their progress over time.

Eligibility criteria

Qualifiers

Adult ≥ 18 years of age

Red group: established diagnosis of one or more neurological and/or psychiatric conditions

Yellow group: high-risk to develop one or more neurological and/or psychiatric conditions

family history (first degree relative) one or more neurological and/or psychiatric conditions

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Neuro-QoL questionnaire

Treatment groups

5,000 Participants
are divided into 3 treatment groups

Locations

2
Chinese University of Hong Kong Hong Kong Hong Kong
The Chinese University of Hong Kong Hong Kong Hong Kong

Sponsors and collaborators

Chinese University of Hong Kong

Lead sponsor